StockNews.com Begins Coverage on Neptune Wellness Solutions (NASDAQ:NEPT)

StockNews.com started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) in a research note published on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock.

Neptune Wellness Solutions Stock Performance

Shares of NASDAQ:NEPT opened at $0.51 on Thursday. The company has a quick ratio of 0.38, a current ratio of 0.87 and a debt-to-equity ratio of 0.94. Neptune Wellness Solutions has a 52-week low of $0.23 and a 52-week high of $10.96. The company has a 50 day moving average of $0.63 and a two-hundred day moving average of $0.98.

Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) last released its earnings results on Friday, December 16th. The biotechnology company reported ($0.79) EPS for the quarter. The business had revenue of $11.99 million for the quarter. Neptune Wellness Solutions had a negative net margin of 149.78% and a negative return on equity of 75.30%. Sell-side analysts predict that Neptune Wellness Solutions will post -11.35 EPS for the current fiscal year.

Hedge Funds Weigh In On Neptune Wellness Solutions

Institutional investors and hedge funds have recently made changes to their positions in the business. Citadel Advisors LLC purchased a new position in shares of Neptune Wellness Solutions during the 3rd quarter valued at approximately $43,000. Capital Wealth Alliance LLC bought a new position in Neptune Wellness Solutions during the second quarter worth $57,000. Virtu Financial LLC bought a new position in Neptune Wellness Solutions during the third quarter worth $64,000. Renaissance Technologies LLC lifted its stake in Neptune Wellness Solutions by 12.6% during the third quarter. Renaissance Technologies LLC now owns 128,684 shares of the biotechnology company’s stock worth $196,000 after purchasing an additional 14,395 shares during the last quarter. Finally, Morgan Stanley lifted its stake in Neptune Wellness Solutions by 26,898.7% during the fourth quarter. Morgan Stanley now owns 544,833 shares of the biotechnology company’s stock worth $172,000 after purchasing an additional 542,815 shares during the last quarter. 5.07% of the stock is currently owned by hedge funds and other institutional investors.

Neptune Wellness Solutions Company Profile

(Get Rating)

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.